Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GraftAssureDx Study: Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring

NCT07060716 is registered in ClinicalTrials.gov with Insight Molecular Diagnostics as lead sponsor.

NCT NCT07060716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07060716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GraftAssureDx Study: Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring
Lead sponsor
Insight Molecular Diagnostics
Phase
Observational
Overall status
Recruiting
Start date
September 8, 2025
Completion date
December 31, 2025
Enrollment
125 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

cell-free dna, kidney transplant rejection